MedTrace Logo

Bilateral Uterine Artery Ligation in PPC Technique for Management of PAS

NCT05314595 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 130

Last updated 2022-04-06

No results posted yet for this study

Summary

Aim of the study

Primary outcomes:

1. The effect of bilateral uterine artery ligation in reducing intraoperative bleeding in women underwent PPC as a conservative surgical technique.
2. Decrease surgical time.

Secondary outcomes:

1. Associated maternal morbidity and mortality.
2. Amount of blood transfusion
3. Difference in hematocrit value before and after delivery

Conditions

  • Placenta Accreta

Interventions

PROCEDURE

bilateral uterine artery ligation

* Spinal anaethesia with intrathecal morphia * Transverse skin incision * Adequate dissection of the bladder. * Incision of the uterus above placental edge. * Delivery of the fetus. * Delayed cord clamping (60 seconds) if the baby appears well. * Exteriorization of the uterus. * Start Oxytocin infusion and uterine massage to ensure good uterine contractions immediately after delivery of the fetus. No trials of placental delivery will be made at this point. * At this point, a gentile trial to deliver the placenta is performed * A catheter is placed in the cervix from above to secure the cervical opening * Compression is applied to the site of bleeding from placenta site * Placental pouch is marked by multiple allies and is closed down to the multiple-8 suture. * Blood loss is measured using the suction device and coated socked towels. In modified PPC, Bilateral uterine artery ligation will be done after exteriorization of the uterus in order to minimize the blood loss.

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Principal Investigators

  • Kamal M Zahran, Professor · Assiut medical school

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
16 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-04-01
Primary Completion
2022-08-01
Completion
2022-09-01

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05314595 on ClinicalTrials.gov